03-2458. Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Submit written comments on the collection of information by March 5, 2003.

    ADDRESSES:

    Submit written comments on the collection of information to the Office of Information and Regulatory Affairs, OMB, New Executive Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: Stuart Shapiro, Desk Officer for FDA.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Peggy Robbins, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Notice of a Claim for GRAS Exemption Based on a GRAS Determination (OMB Control Number 0910-0342)—Extension

    Description: Section 409 of the act (21 U.S.C. 348) establishes a premarket approval requirement for ``food additives;'' section 201(s) of the act (21 U.S.C. 321) provides an exemption from the definition of ``food additive'' and thus from the premarket approval requirement, for uses of substances that are generally recognized as safe (GRAS) by qualified experts. FDA is proposing a voluntary procedure whereby members of the food industry who determine that use of a substance satisfies the statutory exemption may notify FDA of that determination. The notice would include a detailed summary of the data and information that support the GRAS determination, and the notifier would maintain a record of such data and information. FDA would make the information describing the GRAS claim, and the agency's response to the notice, available in a publicly accessible file; the entire GRAS notice would be publicly available consistent with the Freedom of Information Act and other Federal disclosure statutes.

    Description of Respondents: Manufacturers of Substances Used in Food and Feed.

    In the Federal Register of October 31, 2002 (67 FR 66404), the agency requested comments on the proposed collection of information. No comments were received that pertained to this collection of information.

    FDA estimates the burden of this collection of information as follows:

    Table 1.—Estimated Annual Reporting Burden1

    21 CFR SectionNo. of RespondentsAnnual Frequency per ResponseTotal Annual ­ResponsesHours per ResponseTotal Hours
    170.36501501507,500
    570.36101101501,500
    Total9,000
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 2.—Estimated Annual Recordkeeping Burden1

    21 CFR SectionNo. of ­RecordkeepersAnnual Frequency of RecordkeepingTotal Annual ­RecordsHours per ­RecordkeeperTotal Hours
    170.36(c)(v)5015015750
    570.36(c)(v)1011015150
    Total900
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    Start Printed Page 5295

    The reporting requirement is for a proposed rule (62 FR 18937, April 17, 1997) that has not yet been issued as a final rule. In developing the proposed rule, FDA solicited input from representatives of the food industry on the reporting requirements, but could not fully discuss with those representatives the details of the proposed notification procedure. FDA received no comments on the agency's estimate of the hourly reporting requirements, and thus has no basis to revise that estimate at this time. During 1998, FDA received 12 notices that were submitted under the terms of the proposed rule. FDA received 23 notices in 1999, 30 notices in 2000, and 28 notices in 2001. To date, the number of annual notices is less than FDA's estimate; however, the number of annual notices could increase when the proposed rule becomes final.

    Start Signature

    Dated: January 28, 2003.

    Margaret M. Dotzel,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 03-2458 Filed 1-31-03; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
02/03/2003
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
03-2458
Dates:
Submit written comments on the collection of information by March 5, 2003.
Pages:
5294-5295 (2 pages)
Docket Numbers:
Docket No. 02N-0454
PDF File:
03-2458.Pdf